Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

636224

human indexable
published
registered interest
answer date	16/11/2016
date	14/11/2016
date tabled	14/11/2016
ddp created	14/11/2016 23:31:24
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
ddp modified	14/11/2016 23:36:58 21/11/2016 14:31:02
hansard heading	Public Health England: Staff
house id	1
identifier	528601
legislature	25259
parliament number	56
question first answered	21/11/2016 13:59:22
question text	To ask the Secretary of State for Health, with reference to item 7 of the substantive hearing of the Conduct and Competence Committee at the Nursing and Midwifery Council of 13 and 14 September 2016 on Pauline Cafferkey that found that the evidence indicates that PHE Screening staff were not properly prepared to receive so many travellers from at risk countries, whether he has made an assessment of the implications for his policies of that finding; and what steps he plans to take to ensure health screening of such travellers is adequately planned for and resourced in future.
session	2016/17
session number	2
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
title	House of Commons Tabled Parliamentary Question 2016/17 528601
type	WrittenParliamentaryQuestion
uin	528601
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4393 label Biography information for Stuart C McDonald
publisher	25259
tabling member	4393 label Biography information for Stuart C McDonald

709966

human indexable
published
registered interest
answer date	14/03/2017
date	10/03/2017
date tabled	10/03/2017
ddp created	10/03/2017 17:10:31
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
ddp modified	10/03/2017 17:17:50 16/03/2017 11:03:41
hansard heading	Bowel Cancer: Screening
house id	1
identifier	67382
legislature	25259
parliament number	56
question first answered	16/03/2017 10:26:28
question text	To ask the Secretary of State for Health, what plans he has to reduce the screening age for bowel cancer to 50-years old.
session	2016/17
session number	2
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
title	House of Commons Tabled Parliamentary Question 2016/17 67382
type	WrittenParliamentaryQuestion
uin	67382
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4393 label Biography information for Stuart C McDonald
publisher	25259
tabling member	4393 label Biography information for Stuart C McDonald

720505

human indexable
published
registered interest
answer date	19/04/2017
date	13/04/2017
date tabled	13/04/2017
ddp created	13/04/2017 18:25:21
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
ddp modified	13/04/2017 18:41:36 24/04/2017 17:50:05
hansard heading	Human Papillomavirus: Vaccination
house id	1
identifier	70973
legislature	25259
parliament number	56
question first answered	24/04/2017 17:18:32
question text	To ask the Secretary of State for Health, how many reports of (a) all adverse and (b) serious adverse reactions to (i) Cervarix, (ii) Gardasil and (iii) generic human papilloma virus vaccines the Medicines and Healthcare Products Regulatory Agency has received to date.
session	2016/17
session number	2
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
title	House of Commons Tabled Parliamentary Question 2016/17 70973
type	WrittenParliamentaryQuestion
uin	70973
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4393 label Biography information for Stuart C McDonald
publisher	25259
tabling member	4393 label Biography information for Stuart C McDonald

720508

human indexable
published
registered interest
answer date	19/04/2017
date	13/04/2017
date tabled	13/04/2017
ddp created	13/04/2017 18:25:24
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
ddp modified	13/04/2017 18:41:40 24/04/2017 17:19:02
hansard heading	Drugs: Research
house id	1
identifier	70879
legislature	25259
parliament number	56
question first answered	24/04/2017 16:47:49
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that new drugs developed in part with financial support from government are made available to NHS patients.
session	2016/17
session number	2
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
title	House of Commons Tabled Parliamentary Question 2016/17 70879
type	WrittenParliamentaryQuestion
uin	70879
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4393 label Biography information for Stuart C McDonald
publisher	25259
tabling member	4393 label Biography information for Stuart C McDonald

720509

human indexable
published
registered interest
answer date	19/04/2017
date	13/04/2017
date tabled	13/04/2017
ddp created	13/04/2017 18:25:25
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
ddp modified	13/04/2017 18:41:42 24/04/2017 17:39:02
hansard heading	Cancer: Drugs
house id	1
identifier	70880
legislature	25259
parliament number	56
question first answered	24/04/2017 17:06:50
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that existing and cost-effective drugs which have been shown to be effective in reducing the risk of recurrence and spread of incurable cancer are repurposed as quickly as possible.
session	2016/17
session number	2
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
title	House of Commons Tabled Parliamentary Question 2016/17 70880
type	WrittenParliamentaryQuestion
uin	70880
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4393 label Biography information for Stuart C McDonald
publisher	25259
tabling member	4393 label Biography information for Stuart C McDonald